Larry Kociolek to Bacterial Toxins
This is a "connection" page, showing publications Larry Kociolek has written about Bacterial Toxins.
Connection Strength
1.948
-
Identification of Clostridium innocuum hypothetical protein that is cross-reactive with C. difficile anti-toxin antibodies. Anaerobe. 2022 Jun; 75:102555.
Score: 0.681
-
Lack of false-positive results for Clostridioides difficile toxins A and B using two commercial enzyme immunoassays in pediatric patients. Infect Control Hosp Epidemiol. 2019 07; 40(7):825-826.
Score: 0.556
-
Intestinal bile acids provide a surmountable barrier against C. difficile TcdB-induced disease pathogenesis. Proc Natl Acad Sci U S A. 2023 05 09; 120(19):e2301252120.
Score: 0.184
-
Baseline stool toxin concentration is associated with risk of recurrence in children with Clostridioides difficile infection. Infect Control Hosp Epidemiol. 2023 09; 44(9):1403-1409.
Score: 0.180
-
Stool Toxin Concentration Does Not Distinguish Clostridioides difficile Infection from Colonization in Children Less Than 3 Years of Age. J Pediatric Infect Dis Soc. 2022 Oct 25; 11(10):454-458.
Score: 0.177
-
Risk factors for Clostridioides (Clostridium) difficile infection following solid organ transplantation in children. Transpl Infect Dis. 2019 Oct; 21(5):e13149.
Score: 0.142
-
Clostridium difficile-Diagnostic and Clinical Challenges. Clin Chem. 2016 Feb; 62(2):310-4.
Score: 0.028